Citadel Advisors »

Elicio Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Elicio Therapeutics (ELTX) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Elicio Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Elicio Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Elicio Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $117k 14k 8.34
2023-09-30 $136k 16k 8.40

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Tesla Motors Call Option (TSLA)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Advanced Micro Devices Call Option (AMD)
Broadcom Call Option (AVGO)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl C Call Option (GOOG)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl A Call Option (GOOGL)

View all positions for Citadel Advisors

Top funds holding Elicio Therapeutics

Vanguard Group
CM Management
Geode Capital Management
Meyer Handelman
Bridgeway Capital Management
Atlantic Trust
Steward Partners Investment Advisory
Bank of America Corporation
BlackRock
Citigroup
Northwest Capital Management
Morgan Stanley
Efficient Wealth Management
Wells Fargo & Company
UBS Group

View all funds holding Elicio Therapeutics